US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vigil Neuroscience, Inc.

1.70

-0.0100-0.58%

Volume:62.03K

Turnover:106.80K

Market Cap:79.34M

PE:-0.82

High:1.78

Open:1.75

Low:1.68

Close:1.71

Loading ...

Overview Company News Filings

Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference

Vigil Neuroscience Files Secondary Stock Shelf

MT Newswires Live

Vigil Neuroscience- Files Prospectus to Offer & Resale, From Time to Time, of up to 5.4 Mln Shares of Common Stock by Selling Stockholder

THOMSON REUTERS

Vigil Neuroscience (VIGL) Upgraded to Buy: Here's What You Should Know

Vigil Neuroscience Is Maintained at Buy by HC Wainwright & Co.

Vigil Neuroscience price target lowered to $13 from $24 at Wedbush

Wedbush Cuts Price Target on Vigil Neuroscience to $13 From $24, Keeps Outperform Rating

MT Newswires Live

Vigil Neuroscience Faces Market Risks from Preferred Stock Issuance and Potential Share Dilution

Vigil Neuroscience Q4 2024 GAAP EPS $(0.57) Misses $(0.53) Estimate

BRIEF-Vigil Neuroscience Q4 EPS USD -0.57 Vs. IBES Estimate USD -0.53

Vigil Neuroscience- on Track to Report Final Analysis From Ignite Phase 2 Clinical Trial Evaluating Iluzanebart in Alsp in Q2 2025

THOMSON REUTERS

Vigil Neuroscience Inc - Positive Phase 1 Data for Vg-3927 in Alzheimer's Disease, Plans to Initiate Phase 2 Clinical Trial in Q3 2025

THOMSON REUTERS

Press Release: Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

Will Vigil Neuroscience (NASDAQ:VIGL) Spend Its Cash Wisely?

Simply Wall St.

Why Vigil Neuroscience, Inc. (VIGL) is Skyrocketing So Far in 2025

Vigil Neuroscience Inc (VIGL) Receives a Buy from Stifel Nicolaus

Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference

Vigil Neuroscience Shares Jump After Alzheimer's Disease Treatment Shows Favorable Safety Profile in Early Study

MT Newswires Live

Vigil Neuroscience Price Target Maintained With a $17.00/Share by HC Wainwright & Co.

Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VIGL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VIGL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIGL\",,,,,undefined,":{"symbol":"VIGL","market":"US","secType":"STK","nameCN":"Vigil Neuroscience, Inc.","latestPrice":1.7,"timestamp":1745262714916,"preClose":1.71,"halted":0,"volume":62029,"delay":0,"floatShares":27996918,"shares":46671534,"eps":-2.071778,"marketStatus":"Trading","change":-0.01,"latestTime":"04-21 15:16:09 EDT","open":1.75,"high":1.78,"low":1.68,"amount":106796.6070974,"amplitude":0.05848,"askPrice":1.7,"askSize":705,"bidPrice":1.68,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-2.071778,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":2,"adr":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":1.71,"preHourTrading":{"tag":"盘前","latestPrice":1.79,"preClose":1.71,"latestTime":"09:28 EDT","volume":6,"amount":10.5400002,"timestamp":1745242103628},"postHourTrading":{"tag":"盘后","latestPrice":1.71,"preClose":1.71,"latestTime":"18:11 EDT","volume":226,"amount":393.59,"timestamp":1744927915236},"volumeRatio":0.673743},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VIGL\",,,,,undefined,":{"symbol":"VIGL","floatShares":27996918,"roa":"-43.36%","roe":"-89.69%","lyrEps":-2.071778,"volumeRatio":0.673743,"shares":46671534,"dividePrice":0,"high":1.78,"amplitude":0.05848,"preClose":1.71,"low":1.68,"week52Low":1.312,"pbRate":"1.11","week52High":6.06,"institutionHeld":0,"latestPrice":1.7,"committee":-0.170124,"eps":-2.071778,"divideRate":0,"volume":62029,"delay":0,"ttmEps":-2.071778,"open":1.75,"prevYearClose":1.7,"prevWeekClose":1.71,"prevMonthClose":1.78,"prevQuarterClose":1.78,"fiveDayClose":1.49,"twentyDayClose":1.89,"sixtyDayClose":2.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VIGL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524618914","title":"Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524618914","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524618914?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:00","pubTimestamp":1743591600,"startTime":"0","endTime":"0","summary":"- Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 -- First presentation of topline clinical data from Phase 1 SAD/MAD trial of VG-3927 for the potential treatment of Alzheimer’s disease  -. WATERTOWN, Mass., April 02, 2025  -- Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today presented data highlighting its oral small molecule program, including its lead clinical candidate VG-3927, in two oral presentations at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases being held April 1 – April 5 in Vienna, Austria.Oral presentation by Christian Mirescu, Ph.D., Senior Vice President, Neuroimmunology: Small Molecule TREM2 Agonists as Next-Generation Therapeutics for Alzheimer’s DiseaseDate and Time: Wednesday, April 2, 2025, 3:20 PM – 3:35 PM Session: TREM2, Microglia: From Mechanisms to Potenti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vigil-neuroscience-presents-data-small-110000638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CET","VIGL","BK4023","LU1169590202.USD","BK4139","BK4081","BK4563","PD","PK","PAM","VG","LU1169589451.USD","BK4181","CSF","BK4213","BK4218","ARIA"],"gpt_icon":0},{"id":"2523926638","title":"Vigil Neuroscience Files Secondary Stock Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2523926638","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523926638?lang=en_us&edition=fundamental","pubTime":"2025-03-31 23:01","pubTimestamp":1743433298,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience  on Monday filed a registration statement for the resale of up to around 5.4 million shares, issuable upon conversion of about 538,000 shares of series A non-voting convertible preferred stock, from time to time by Aventis.The company said it will not receive any proceeds from the sale of the shares as it is not selling the securities.The selling stockholder bought the shares in a private placement on July 1, 2024, according to the filing.Price: 1.80, Change: -0.11, Percent Change: -5.76","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VIGL","BK4139"],"gpt_icon":0},{"id":"2523943973","title":"Vigil Neuroscience- Files Prospectus to Offer & Resale, From Time to Time, of up to 5.4 Mln Shares of Common Stock by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2523943973","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523943973?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:48","pubTimestamp":1743421699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0XH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VIGL"],"gpt_icon":0},{"id":"2520938506","title":"Vigil Neuroscience (VIGL) Upgraded to Buy: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2520938506","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520938506?lang=en_us&edition=fundamental","pubTime":"2025-03-18 00:00","pubTimestamp":1742227209,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience, Inc.  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.As such, the Zacks rating upgrade for Vigil Neuroscience is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock pri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vigil-neuroscience-vigl-upgraded-buy-160009457.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VIGL"],"gpt_icon":0},{"id":"2519806038","title":"Vigil Neuroscience Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806038?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:43","pubTimestamp":1741956180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VIGL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 08:43 ET (12:43 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIGL"],"gpt_icon":0},{"id":"2519806533","title":"Vigil Neuroscience price target lowered to $13 from $24 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806533?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955413,"startTime":"0","endTime":"0","summary":"Wedbush lowered the firm’s price target on Vigil Neuroscience (VIGL) to $13 from $24 and keeps an Outperform rating on the shares. For Vigil, the m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vigil-neuroscience-price-target-lowered-to-13-from-24-at-wedbush?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vigil-neuroscience-price-target-lowered-to-13-from-24-at-wedbush?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VIGL"],"gpt_icon":0},{"id":"2519992877","title":"Wedbush Cuts Price Target on Vigil Neuroscience to $13 From $24, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519992877","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519992877?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:14","pubTimestamp":1741950886,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience (VIGL) has an average rating of buy and mean price target of $15.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VIGL"],"gpt_icon":0},{"id":"2519284980","title":"Vigil Neuroscience Faces Market Risks from Preferred Stock Issuance and Potential Share Dilution","url":"https://stock-news.laohu8.com/highlight/detail?id=2519284980","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519284980?lang=en_us&edition=fundamental","pubTime":"2025-03-14 14:01","pubTimestamp":1741932065,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience, Inc. (VIGL) has disclosed a new risk, in the Share Price & Shareholder Rights category. Vigil Neuroscience, Inc. faces a signif...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vigil-neuroscience-faces-market-risks-from-preferred-stock-issuance-and-potential-share-dilution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vigil-neuroscience-faces-market-risks-from-preferred-stock-issuance-and-potential-share-dilution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VIGL"],"gpt_icon":0},{"id":"2519880993","title":"Vigil Neuroscience Q4 2024 GAAP EPS $(0.57) Misses $(0.53) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2519880993","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519880993?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:17","pubTimestamp":1741864627,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience Q4 2024 GAAP EPS $(0.57) Misses $(0.53) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44298636/vigil-neuroscience-q4-2024-gaap-eps-0-57-misses-0-53-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vigil Neuroscience Q4 2024 GAAP EPS $(0.57) Misses $(0.53) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIGL"],"gpt_icon":0},{"id":"2519887433","title":"BRIEF-Vigil Neuroscience Q4 EPS USD -0.57 Vs. IBES Estimate USD -0.53","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887433","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887433?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863651,"startTime":"0","endTime":"0","summary":"BRIEF-Vigil Neuroscience Q4 EPS USD -0.57 Vs. IBES Estimate USD -0.53\n\n\nMar 13 (Reuters) - Vigil Neuroscience Q4 operating expenses USD 25.114 million.\n\nQ4 operating income USD -25.114 million vs. IBES estimate USD -23 million\nQ4 net income USD -23.831 million vs. IBES estimate USD -22 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLX74F72A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIGL"],"gpt_icon":0},{"id":"2519888712","title":"Vigil Neuroscience- on Track to Report Final Analysis From Ignite Phase 2 Clinical Trial Evaluating Iluzanebart in Alsp in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519888712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519888712?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLX74F72A:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VIGL"],"gpt_icon":0},{"id":"2519887485","title":"Vigil Neuroscience Inc - Positive Phase 1 Data for Vg-3927 in Alzheimer's Disease, Plans to Initiate Phase 2 Clinical Trial in Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887485","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887485?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLX74F72A:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VIGL","BK4139"],"gpt_icon":0},{"id":"2519887161","title":"Press Release: Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887161","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887161?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates. -- Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease ; plans to initiate Phase 2 clinical trial in Q3 2025 --. -- On track to report final analysis from IGNITE Phase 2 clinical trial evaluating iluzanebart in ALSP in Q2 2025 --. WATERTOWN, Mass., March 13, 2025  -- Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided updates on recent progress.Final analysis from IGNITE Phase 2 clinical trial planned for second quarter of 2025:. -- The Company plans to report the final analysis from the IGNITE Phase 2. clinical trial, including all patients at 12 months dosed with either 20. iluzanebart in ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","PK","BK4181","BK4588","BK4099","PD","BK4213","BK4604","03160","BK4555","CSF","LU1169589451.USD","BK4139","VIGL","LU1169590202.USD","BK4218","VG","BK4585","BK4023"],"gpt_icon":0},{"id":"2517154050","title":"Will Vigil Neuroscience (NASDAQ:VIGL) Spend Its Cash Wisely?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154050","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154050?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:55","pubTimestamp":1741265737,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?Given this risk, we thought we'd take a look at whether Vigil Neuroscience  shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.Since it has a market capitalisation of US$92m, Vigil Neuroscience's US$49m in cash burn equates to about 53% of its market value. That's high expenditure relative to the value of the entire company, so if it does have to issue shares to fund more growth, that could end up really hurting shareholders r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vigil-neuroscience-nasdaq-vigl-spend-125537486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","TSYW.SI","BK4112","NQmain","QID","SQQQ","NDAQ",".IXIC","NVIW.SI","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BKPKM429.USD","BK4139","VIGL","QLD","USJW.SI","MNQmain","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","TQQQ","USAW.SI","IE00BGHQF748.EUR","BK4585","PSQ"],"gpt_icon":1},{"id":"2516561465","title":"Why Vigil Neuroscience, Inc. (VIGL) is Skyrocketing So Far in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516561465","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516561465?lang=en_us&edition=fundamental","pubTime":"2025-03-02 05:51","pubTimestamp":1740865881,"startTime":"0","endTime":"0","summary":"We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025.In this article, we are going to take a look at where Vigil Neuroscience, Inc.  stands against the other biotech stocks.No matter the market environment, you’ll always find entertainment in the biotech space. There will always be biotech stocks making huge swings in both directions and these stocks can make or break your portfolio in a very small amount of time due to the nature of how important clinical trial results are for these companies.The United Nations forecasts that the over-65 age group will grow by 150% from 800 million in 2024 to 2 billion by 2067. This \"older, richer & sicker\" population is expected to push global healthcare spending on medicines up 12% to $2.3 trillion by 2028. If you combine that with AI making breakthroughs in healthcare more frequent, you’ll see many more biotech stocks starting to pop to the upside over the coming years.Vigil Neuroscience, Inc.  is a bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-vigil-neuroscience-inc-vigl-215121382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain",".IXIC","MNQmain","TQQQ","USAW.SI","TSYW.SI","BK4139","SQQQ","VIGL","USJW.SI","QLD","QID","NVIW.SI","PSQ"],"gpt_icon":1},{"id":"2510851914","title":"Vigil Neuroscience Inc (VIGL) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2510851914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510851914?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:46","pubTimestamp":1739191592,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report), with a pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vigil-neuroscience-inc-vigl-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vigil-neuroscience-inc-vigl-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SF","BK4127","VIGL"],"gpt_icon":0},{"id":"2507517642","title":"Vigil Neuroscience to Present at Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507517642","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507517642?lang=en_us&edition=fundamental","pubTime":"2025-01-30 20:00","pubTimestamp":1738238400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Jan. 30, 2025  -- Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference on February 6, 2025, at 10:30 a.m. ET.To register for the live webcast, please click here. The webcast will also be available on the Company’s website in the “Investors” section under “Events & Presentations.” An archived webcast will be available for approximately 90 days following the event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vigil-neuroscience-present-guggenheim-securities-120000141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VIGL","BK4011","BK4139","SMID"],"gpt_icon":0},{"id":"2505420770","title":"Vigil Neuroscience Shares Jump After Alzheimer's Disease Treatment Shows Favorable Safety Profile in Early Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2505420770","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505420770?lang=en_us&edition=fundamental","pubTime":"2025-01-24 02:48","pubTimestamp":1737658104,"startTime":"0","endTime":"0","summary":"Vigil Neuroscience  shares surged over 26% in recent Thursday trading following positive results from a Phase 1 trial of VG-3927, a potential treatment for Alzheimer's disease, supporting its advancement to a mid-stage clinical trial.The initial Phase 1 study demonstrated a favorable safety and tolerability profile for VG-3927 across all subjects, including elderly participants.VG-3927 achieved a dose-dependent reduction of soluble TREM2 levels in cerebrospinal fluid by about 50% and showed activation of the TREM2 receptor, which is believed to support brain health through microglial activity.Based on these findings, Vigil said it plans to advance a once-daily oral dose of 25 milligrams into a Phase 2 trial, expected to begin in Q3.Price: 2.56, Change: +0.53, Percent Change: +26.11","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","VIGL"],"gpt_icon":0},{"id":"2505410970","title":"Vigil Neuroscience Price Target Maintained With a $17.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505410970","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505410970?lang=en_us&edition=fundamental","pubTime":"2025-01-24 01:57","pubTimestamp":1737655020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VIGL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2025 12:57 ET (17:57 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIGL"],"gpt_icon":0},{"id":"2505045131","title":"Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045131","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505045131?lang=en_us&edition=fundamental","pubTime":"2025-01-24 00:33","pubTimestamp":1737649998,"startTime":"0","endTime":"0","summary":"On Thursday, Vigil Neuroscience Inc.  released data from its completed Phase 1 trial evaluating VG-3927 as a potential treatment for Alzheimer’s disease.Key takeaways from the Phase 1 clinical trial ofVG-3927 include:. Demonstrated a favorable safety and tolerability profile across all cohorts, including the elderly cohort.All related adverse events were mild or moderate in severity and self-resolving without drug discontinuations. No serious AEs were reported.Highly brain penetrant with a favorable and predictable PK profile that supports once-daily dosing.Achieved robust and dose-dependent reduction of sTREM2 of up to approximately 50% in the cerebral spinal fluid , demonstrating a strong PK/PD relationship, sustained target engagement, and TREM2 agonist activity.PK and sTREM2 reduction observed in the Alzheimer’s cohort was consistent with healthy volunteers and similar across evaluated TREM2 and ApoE genetic variants supporting development in Alzheimer’s disease across genotypes.An","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vigil-neurosciences-alzheimers-candidate-shows-163318630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","LU0267386448.USD","LU0912757837.SGD","BK4581","LU2133065610.SGD","LU1720051108.HKD","LU0158827781.USD","VIGL","LU0098860793.USD","LU1989772923.USD","BK4516","BK4534","CSF","LU1074936037.SGD","BK4504","LU2111349929.HKD","LU0795875086.SGD","LU1162221912.USD","LU1548497426.USD","LU1720051017.SGD","LU2028103732.USD","LU2357305700.SGD","LU1732800096.USD","LU2271345857.HKD","LU2089284900.SGD","LU0158827948.USD","IE00BKVL7J92.USD","BK4139","LU0006306889.USD","LU0106831901.USD","LU0795875169.SGD","LU1732799900.SGD","LU0320765646.SGD","LU0971096721.USD","BK4588","LU0314104364.USD","LU0225283273.USD","LU1363072403.SGD","LU2023251221.USD","IE00BZ1G4Q59.USD","LU2089283258.USD","LU2347655156.SGD","LU1989772840.SGD","SSI","LU1668664300.SGD","LU0106261372.USD","BK4127"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VIGL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-01-06","symbol":"VIGL","defaultRemindTime":1641479400000,"type":"split","dateTimestamp":1641445200000,"forFactor":500000,"toFactor":180297,"ratio":2.7732019944868744}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VIGL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VIGL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.625,"buy":0.375,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.625,"analysts":8,"updateTime":1733284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VIGL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VIGL","date":"2025-04-17","current":-0.836427,"percent":0.987484,"low":-10.14072,"twenty":-5.707781,"median":-2.644735,"eighty":-1.423644,"high":-0.756378,"avg":-3.443172,"sd":2.284396,"marketCap":70474016},"quantilePoints":[{"date":"2022-01-07","current":-6.262508,"twenty":-6.930839,"median":-6.930839,"eighty":-6.52984,"marketCap":357539131},{"date":"2022-01-14","current":-6.930839,"twenty":-6.930839,"median":-6.906086,"eighty":-6.02785,"marketCap":395695482},{"date":"2022-01-21","current":-6.940741,"twenty":-6.930839,"median":-6.930839,"eighty":-6.386273,"marketCap":396260761},{"date":"2022-01-28","current":-7.252628,"twenty":-6.930839,"median":-6.930839,"eighty":-6.737766,"marketCap":414067057},{"date":"2022-02-04","current":-6.762519,"twenty":-6.930839,"median":-6.896185,"eighty":-6.673408,"marketCap":386085734},{"date":"2022-02-11","current":-7.747688,"twenty":-6.960543,"median":-6.930839,"eighty":-6.737766,"marketCap":442331020},{"date":"2022-02-18","current":-7.871453,"twenty":-7.42689,"median":-6.930839,"eighty":-6.758558,"marketCap":449397011},{"date":"2022-02-25","current":-7.564516,"twenty":-7.470455,"median":-6.930839,"eighty":-6.762519,"marketCap":431873354},{"date":"2022-03-04","current":-7.316986,"twenty":-7.871453,"median":-6.940741,"eighty":-6.816976,"marketCap":417741373},{"date":"2022-03-11","current":-6.27241,"twenty":-7.965515,"median":-6.985296,"eighty":-6.816976,"marketCap":358104411},{"date":"2022-03-18","current":-5.099118,"twenty":-7.871453,"median":-6.930839,"eighty":-6.658556,"marketCap":291118818},{"date":"2022-03-25","current":-4.819654,"twenty":-7.807095,"median":-6.930839,"eighty":-5.911016,"marketCap":208609094},{"date":"2022-04-01","current":-5.100474,"twenty":-7.747688,"median":-6.930839,"eighty":-5.411005,"marketCap":220763825},{"date":"2022-04-08","current":-4.349444,"twenty":-7.564516,"median":-6.920938,"eighty":-5.099118,"marketCap":188256987},{"date":"2022-04-14","current":-4.421282,"twenty":-7.489267,"median":-6.854105,"eighty":-4.673367,"marketCap":191366337},{"date":"2022-04-22","current":-3.742089,"twenty":-7.34966,"median":-6.762519,"eighty":-4.587162,"marketCap":161968849},{"date":"2022-04-29","current":-2.213906,"twenty":-7.317481,"median":-6.695685,"eighty":-4.406914,"marketCap":95824502},{"date":"2022-05-06","current":-2.024516,"twenty":-7.301144,"median":-6.27241,"eighty":-4.221443,"marketCap":87627126},{"date":"2022-05-13","current":-1.289289,"twenty":-7.261539,"median":-5.891214,"eighty":-3.911963,"marketCap":65013674},{"date":"2022-05-20","current":-1.463062,"twenty":-7.189261,"median":-5.475363,"eighty":-3.265348,"marketCap":73776387},{"date":"2022-05-27","current":-1.608808,"twenty":-7.106091,"median":-5.205603,"eighty":-2.607054,"marketCap":81125759},{"date":"2022-06-03","current":-1.900299,"twenty":-7.038762,"median":-5.099796,"eighty":-2.200845,"marketCap":95824502},{"date":"2022-06-10","current":-1.681681,"twenty":-7.005098,"median":-4.793531,"eighty":-1.89133,"marketCap":84800445},{"date":"2022-06-17","current":-1.401401,"twenty":-6.981336,"median":-4.659652,"eighty":-1.762402,"marketCap":70667037},{"date":"2022-06-24","current":-1.631231,"twenty":-6.955593,"median":-4.600876,"eighty":-1.713072,"marketCap":82256431},{"date":"2022-07-01","current":-1.328528,"twenty":-6.93678,"median":-4.480058,"eighty":-1.642442,"marketCap":66992351},{"date":"2022-07-08","current":-2.404804,"twenty":-6.930839,"median":-4.421282,"eighty":-1.636837,"marketCap":121264636},{"date":"2022-07-15","current":-3.318517,"twenty":-6.930839,"median":-4.293933,"eighty":-1.663743,"marketCap":167339544},{"date":"2022-07-22","current":-4.148146,"twenty":-6.930839,"median":-4.205769,"eighty":-1.686165,"marketCap":209174431},{"date":"2022-07-29","current":-3.727726,"twenty":-6.930839,"median":-4.16216,"eighty":-1.708588,"marketCap":187974319},{"date":"2022-08-05","current":-4.344343,"twenty":-6.930839,"median":-4.04464,"eighty":-1.726526,"marketCap":219067816},{"date":"2022-08-12","current":-3.992706,"twenty":-6.930839,"median":-3.986342,"eighty":-1.728768,"marketCap":223887018},{"date":"2022-08-19","current":-4.566178,"twenty":-6.930839,"median":-4.009848,"eighty":-1.739979,"marketCap":256043858},{"date":"2022-08-26","current":-5.314524,"twenty":-6.926879,"median":-4.16216,"eighty":-1.750069,"marketCap":298006601},{"date":"2022-09-02","current":-5.415994,"twenty":-6.905096,"median":-4.205769,"eighty":-1.757917,"marketCap":303696465},{"date":"2022-09-09","current":-6.094579,"twenty":-6.881333,"median":-4.277606,"eighty":-1.771371,"marketCap":341747427},{"date":"2022-09-16","current":-5.473072,"twenty":-6.826877,"median":-4.346894,"eighty":-1.776976,"marketCap":306897013},{"date":"2022-09-23","current":-5.707722,"twenty":-6.816976,"median":-4.440874,"eighty":-1.789411,"marketCap":320054823},{"date":"2022-09-30","current":-5.771141,"twenty":-6.762519,"median":-4.568833,"eighty":-1.877877,"marketCap":323610987},{"date":"2022-10-07","current":-5.542833,"twenty":-6.757568,"median":-4.610672,"eighty":-1.900299,"marketCap":310808794},{"date":"2022-10-14","current":-10.128036,"twenty":-6.816976,"median":-4.67825,"eighty":-2.004924,"marketCap":567919502},{"date":"2022-10-21","current":-9.252852,"twenty":-6.930839,"median":-4.728224,"eighty":-2.024516,"marketCap":518844429},{"date":"2022-10-28","current":-10.14072,"twenty":-6.930839,"median":-4.841951,"eighty":-2.074073,"marketCap":568630735},{"date":"2022-11-04","current":-7.870315,"twenty":-6.940741,"median":-4.991086,"eighty":-2.181253,"marketCap":441320039},{"date":"2022-11-11","current":-5.940186,"twenty":-7.005098,"median":-5.092666,"eighty":-2.213906,"marketCap":373245644},{"date":"2022-11-18","current":-7.361527,"twenty":-7.089259,"median":-5.117924,"eighty":-2.32072,"marketCap":462554183},{"date":"2022-11-25","current":-6.223322,"twenty":-7.02193,"median":-5.193179,"eighty":-2.35021,"marketCap":391036190},{"date":"2022-12-02","current":-7.219959,"twenty":-7.106091,"median":-5.268681,"eighty":-2.368452,"marketCap":453658910},{"date":"2022-12-09","current":-6.948149,"twenty":-7.080565,"median":-5.365259,"eighty":-2.375973,"marketCap":436579986},{"date":"2022-12-16","current":-7.101042,"twenty":-7.090483,"median":-5.407158,"eighty":-2.394793,"marketCap":446186881},{"date":"2022-12-23","current":-6.359227,"twenty":-7.080565,"median":-5.454046,"eighty":-2.403683,"marketCap":399575651},{"date":"2022-12-30","current":-7.078391,"twenty":-7.078391,"median":-5.475363,"eighty":-2.475434,"marketCap":444763637},{"date":"2023-01-06","current":-6.642362,"twenty":-7.078391,"median":-5.536491,"eighty":-2.579322,"marketCap":417366197},{"date":"2023-01-13","current":-6.766942,"twenty":-7.05574,"median":-5.595183,"eighty":-2.674973,"marketCap":425194037},{"date":"2023-01-20","current":-7.191646,"twenty":-7.067066,"median":-5.63479,"eighty":-2.752036,"marketCap":451879855},{"date":"2023-01-27","current":-6.291274,"twenty":-7.018431,"median":-5.656987,"eighty":-3.025019,"marketCap":395305921},{"date":"2023-02-03","current":-5.974162,"twenty":-7.005098,"median":-5.688697,"eighty":-3.167388,"marketCap":375380510},{"date":"2023-02-10","current":-6.6367,"twenty":-7.005034,"median":-5.707722,"eighty":-3.302105,"marketCap":417010386},{"date":"2023-02-17","current":-7.086885,"twenty":-7.005034,"median":-5.731878,"eighty":-3.330342,"marketCap":445297353},{"date":"2023-02-24","current":-6.597061,"twenty":-7.004776,"median":-5.786996,"eighty":-3.377641,"marketCap":414519710},{"date":"2023-03-03","current":-6.455493,"twenty":-6.993451,"median":-5.847244,"eighty":-3.569208,"marketCap":405624437},{"date":"2023-03-10","current":-5.379577,"twenty":-6.9708,"median":-5.891214,"eighty":-3.587586,"marketCap":338020364},{"date":"2023-03-17","current":-5.606086,"twenty":-6.965494,"median":-5.840903,"eighty":-3.615614,"marketCap":352252800},{"date":"2023-03-24","current":-6.366007,"twenty":-6.965137,"median":-5.821877,"eighty":-3.638691,"marketCap":434830094},{"date":"2023-03-31","current":-5.10846,"twenty":-6.953812,"median":-5.775967,"eighty":-3.685157,"marketCap":348933329},{"date":"2023-04-06","current":-4.847558,"twenty":-6.949282,"median":-5.73309,"eighty":-3.69679,"marketCap":331112424},{"date":"2023-04-14","current":-5.218038,"twenty":-6.942223,"median":-5.707869,"eighty":-3.72212,"marketCap":356418110},{"date":"2023-04-21","current":-5.103242,"twenty":-6.937607,"median":-5.707722,"eighty":-3.739216,"marketCap":348576911},{"date":"2023-04-28","current":-4.537698,"twenty":-6.936823,"median":-5.665059,"eighty":-3.775443,"marketCap":309947455},{"date":"2023-05-05","current":-4.668242,"twenty":-6.932036,"median":-5.648634,"eighty":-3.84197,"marketCap":318864240},{"date":"2023-05-12","current":-4.470279,"twenty":-6.930839,"median":-5.618935,"eighty":-3.860584,"marketCap":325284325},{"date":"2023-05-19","current":-4.097756,"twenty":-6.930839,"median":-5.577772,"eighty":-3.871098,"marketCap":298177298},{"date":"2023-05-26","current":-4.531383,"twenty":-6.930839,"median":-5.520636,"eighty":-3.877956,"marketCap":329730591},{"date":"2023-06-02","current":-4.953135,"twenty":-6.930839,"median":-5.474217,"eighty":-3.882441,"marketCap":360419802},{"date":"2023-06-09","current":-4.89919,"twenty":-6.930839,"median":-5.437196,"eighty":-3.884683,"marketCap":356494438},{"date":"2023-06-16","current":-4.904094,"twenty":-6.930839,"median":-5.417605,"eighty":-3.901101,"marketCap":356851290},{"date":"2023-06-23","current":-4.904094,"twenty":-6.930839,"median":-5.407158,"eighty":-3.914554,"marketCap":356851290},{"date":"2023-06-30","current":-4.580424,"twenty":-6.929771,"median":-5.385102,"eighty":-3.919819,"marketCap":333299104},{"date":"2023-07-07","current":-4.830532,"twenty":-6.925498,"median":-5.339892,"eighty":-3.925825,"marketCap":351498520},{"date":"2023-07-14","current":-4.438205,"twenty":-6.911037,"median":-5.238911,"eighty":-3.979978,"marketCap":322950417},{"date":"2023-07-21","current":-3.633933,"twenty":-6.881333,"median":-5.222501,"eighty":-3.925825,"marketCap":264426805},{"date":"2023-07-28","current":-3.584893,"twenty":-6.880196,"median":-5.218038,"eighty":-3.884683,"marketCap":260858292},{"date":"2023-08-04","current":-3.599605,"twenty":-6.851883,"median":-5.21282,"eighty":-3.873472,"marketCap":261928846},{"date":"2023-08-11","current":-3.151475,"twenty":-6.84622,"median":-5.202384,"eighty":-3.810481,"marketCap":239275718},{"date":"2023-08-18","current":-2.622292,"twenty":-6.84622,"median":-5.152933,"eighty":-3.727726,"marketCap":199097486},{"date":"2023-08-25","current":-3.023904,"twenty":-6.826877,"median":-5.11497,"eighty":-3.65355,"marketCap":229589894},{"date":"2023-09-01","current":-2.849084,"twenty":-6.823569,"median":-5.10846,"eighty":-3.599605,"marketCap":216316728},{"date":"2023-09-08","current":-2.267928,"twenty":-6.819039,"median":-5.101858,"eighty":-3.563518,"marketCap":172192420},{"date":"2023-09-15","current":-2.702614,"twenty":-6.817162,"median":-5.086215,"eighty":-3.336079,"marketCap":205195968},{"date":"2023-09-22","current":-2.508895,"twenty":-6.7996,"median":-5.042231,"eighty":-3.292705,"marketCap":190487865},{"date":"2023-09-29","current":-2.759312,"twenty":-6.795256,"median":-5.028489,"eighty":-3.170374,"marketCap":209500778},{"date":"2023-10-06","current":-2.598667,"twenty":-6.795256,"median":-4.984371,"eighty":-3.055088,"marketCap":197303815},{"date":"2023-10-13","current":-2.648278,"twenty":-6.795256,"median":-4.966199,"eighty":-2.995293,"marketCap":201070524},{"date":"2023-10-20","current":-3.264871,"twenty":-6.795256,"median":-4.916711,"eighty":-2.969095,"marketCap":247885339},{"date":"2023-10-27","current":-4.063371,"twenty":-6.795256,"median":-4.904094,"eighty":-2.974765,"marketCap":308511420},{"date":"2023-11-03","current":-3.189274,"twenty":-6.791858,"median":-4.904094,"eighty":-2.988402,"marketCap":242145591},{"date":"2023-11-10","current":-2.563972,"twenty":-6.776002,"median":-4.904094,"eighty":-2.960591,"marketCap":202348654},{"date":"2023-11-17","current":-3.032215,"twenty":-6.766942,"median":-4.904094,"eighty":-2.935077,"marketCap":239302398},{"date":"2023-11-24","current":-1.409275,"twenty":-6.766942,"median":-4.89919,"eighty":-2.895231,"marketCap":111220005},{"date":"2023-12-01","current":-1.445644,"twenty":-6.762519,"median":-4.86951,"eighty":-2.849084,"marketCap":114090198},{"date":"2023-12-08","current":-1.568387,"twenty":-6.757568,"median":-4.864861,"eighty":-2.820735,"marketCap":123777102},{"date":"2023-12-15","current":-1.654762,"twenty":-6.732966,"median":-4.848854,"eighty":-2.759312,"marketCap":130593812},{"date":"2023-12-22","current":-1.627486,"twenty":-6.732966,"median":-4.819654,"eighty":-2.716789,"marketCap":128441167},{"date":"2023-12-29","current":-1.677492,"twenty":-6.732875,"median":-4.792415,"eighty":-2.696471,"marketCap":132387683},{"date":"2024-01-05","current":-1.500196,"twenty":-6.73058,"median":-4.781491,"eighty":-2.664582,"marketCap":118395489},{"date":"2024-01-12","current":-1.509288,"twenty":-6.715977,"median":-4.718077,"eighty":-2.626072,"marketCap":119113037},{"date":"2024-01-19","current":-1.336538,"twenty":-6.693327,"median":-4.704363,"eighty":-2.563972,"marketCap":105479617},{"date":"2024-01-26","current":-1.381999,"twenty":-6.670676,"median":-4.67399,"eighty":-2.508895,"marketCap":109067359},{"date":"2024-02-02","current":-1.222887,"twenty":-6.658556,"median":-4.650861,"eighty":-2.404804,"marketCap":96510262},{"date":"2024-02-09","current":-1.291078,"twenty":-6.648025,"median":-4.610672,"eighty":-2.357582,"marketCap":101891875},{"date":"2024-02-16","current":-1.477466,"twenty":-6.642362,"median":-4.590656,"eighty":-2.286827,"marketCap":116601618},{"date":"2024-02-23","current":-1.436552,"twenty":-6.637832,"median":-4.582876,"eighty":-2.207375,"marketCap":113372650},{"date":"2024-03-01","current":-1.582025,"twenty":-6.6367,"median":-4.57425,"eighty":-1.983999,"marketCap":124853425},{"date":"2024-03-08","current":-1.541111,"twenty":-6.618579,"median":-4.563492,"eighty":-1.786924,"marketCap":121624457},{"date":"2024-03-15","current":-1.25471,"twenty":-6.604988,"median":-4.54292,"eighty":-1.746706,"marketCap":99021681},{"date":"2024-03-22","current":-1.381999,"twenty":-6.598193,"median":-4.5383,"eighty":-1.69969,"marketCap":109067359},{"date":"2024-03-28","current":-1.428291,"twenty":-6.58347,"median":-4.521486,"eighty":-1.672037,"marketCap":118031078},{"date":"2024-04-05","current":-1.455071,"twenty":-6.550627,"median":-4.480058,"eighty":-1.659288,"marketCap":120244161},{"date":"2024-04-12","current":-1.463998,"twenty":-6.531373,"median":-4.464825,"eighty":-1.644761,"marketCap":120981855},{"date":"2024-04-19","current":-1.250718,"twenty":-6.52571,"median":-4.438205,"eighty":-1.631231,"marketCap":103356858},{"date":"2024-04-26","current":-1.173401,"twenty":-6.51665,"median":-4.397867,"eighty":-1.609301,"marketCap":96967524},{"date":"2024-05-03","current":-1.24617,"twenty":-6.478144,"median":-4.344343,"eighty":-1.599164,"marketCap":102981014},{"date":"2024-05-10","current":-1.491423,"twenty":-6.448228,"median":-4.293534,"eighty":-1.581527,"marketCap":123464464},{"date":"2024-05-17","current":-1.607195,"twenty":-6.42007,"median":-4.259509,"eighty":-1.581527,"marketCap":133048464},{"date":"2024-05-24","current":-1.629896,"twenty":-6.394335,"median":-4.22773,"eighty":-1.582145,"marketCap":134927680},{"date":"2024-05-31","current":-1.452832,"twenty":-6.387033,"median":-4.19938,"eighty":-1.578799,"marketCap":120269798},{"date":"2024-06-07","current":-1.943163,"twenty":-6.379985,"median":-4.163928,"eighty":-1.56237,"marketCap":160860855},{"date":"2024-06-14","current":-1.984024,"twenty":-6.369643,"median":-4.097756,"eighty":-1.568387,"marketCap":164243443},{"date":"2024-06-21","current":-1.902302,"twenty":-6.366007,"median":-4.04464,"eighty":-1.568387,"marketCap":157478267},{"date":"2024-06-28","current":-2.033965,"twenty":-6.363295,"median":-4.011397,"eighty":-1.572024,"marketCap":168377717},{"date":"2024-07-05","current":-1.79334,"twenty":-6.345636,"median":-3.992706,"eighty":-1.578139,"marketCap":148458032},{"date":"2024-07-12","current":-1.997644,"twenty":-6.287501,"median":-3.961435,"eighty":-1.581029,"marketCap":165370972},{"date":"2024-07-15","current":-1.974944,"twenty":-6.283728,"median":-3.942891,"eighty":-1.581278,"marketCap":163491757},{"date":"2024-08-02","current":-1.82058,"twenty":-6.279956,"median":-3.934358,"eighty":-1.581527,"marketCap":150713091},{"date":"2024-08-09","current":-1.475533,"twenty":-6.266469,"median":-3.912046,"eighty":-1.57946,"marketCap":122149014},{"date":"2024-08-16","current":-1.636295,"twenty":-6.242394,"median":-3.88188,"eighty":-1.564375,"marketCap":137180464},{"date":"2024-08-23","current":-1.622108,"twenty":-6.225587,"median":-3.861601,"eighty":-1.568387,"marketCap":135991038},{"date":"2024-08-30","current":-1.626837,"twenty":-6.216526,"median":-3.820289,"eighty":-1.573842,"marketCap":136387513},{"date":"2024-09-06","current":-1.778171,"twenty":-6.209731,"median":-3.767657,"eighty":-1.578799,"marketCap":149074724},{"date":"2024-09-13","current":-1.740337,"twenty":-6.204068,"median":-3.732015,"eighty":-1.581278,"marketCap":145902921},{"date":"2024-09-20","current":-1.622108,"twenty":-6.175755,"median":-3.713405,"eighty":-1.582105,"marketCap":135991038},{"date":"2024-09-27","current":-1.546441,"twenty":-6.138381,"median":-3.65355,"eighty":-1.568387,"marketCap":129647432},{"date":"2024-10-04","current":-1.60792,"twenty":-6.136116,"median":-3.624773,"eighty":-1.568387,"marketCap":134801612},{"date":"2024-10-11","current":-1.598462,"twenty":-6.123658,"median":-3.587586,"eighty":-1.572024,"marketCap":134008661},{"date":"2024-10-18","current":-1.886942,"twenty":-6.103872,"median":-3.554982,"eighty":-1.578799,"marketCap":158193656},{"date":"2024-10-25","current":-1.693046,"twenty":-6.078123,"median":-3.377641,"eighty":-1.581278,"marketCap":141938168},{"date":"2024-10-31","current":-1.820733,"twenty":-6.050042,"median":-3.340469,"eighty":-1.582065,"marketCap":152643002},{"date":"2024-11-08","current":-1.713601,"twenty":-6.035319,"median":-3.302698,"eighty":-1.582635,"marketCap":141541692},{"date":"2024-11-15","current":-1.5264,"twenty":-6.029657,"median":-3.29322,"eighty":-1.582635,"marketCap":126079154},{"date":"2024-11-22","current":-1.483094,"twenty":-6.022862,"median":-3.276683,"eighty":-1.570205,"marketCap":122502060},{"date":"2024-11-29","current":-1.221081,"twenty":-6.013801,"median":-3.229435,"eighty":-1.565358,"marketCap":100860029},{"date":"2024-12-06","current":-1.141982,"twenty":-5.996813,"median":-3.189274,"eighty":-1.541712,"marketCap":94326586},{"date":"2024-12-13","current":-0.988729,"twenty":-5.995526,"median":-3.163287,"eighty":-1.538838,"marketCap":81668040},{"date":"2024-12-20","current":-0.820645,"twenty":-5.974162,"median":-3.134734,"eighty":-1.5312,"marketCap":67784473},{"date":"2024-12-27","current":-0.820645,"twenty":-5.953804,"median":-3.109498,"eighty":-1.525705,"marketCap":67784473},{"date":"2025-01-03","current":-0.875025,"twenty":-5.943598,"median":-3.061703,"eighty":-1.518747,"marketCap":72276215},{"date":"2025-01-10","current":-0.909631,"twenty":-5.935987,"median":-3.028629,"eighty":-1.509288,"marketCap":75134596},{"date":"2025-01-17","current":-0.934349,"twenty":-5.924615,"median":-3.010747,"eighty":-1.501227,"marketCap":77176297},{"date":"2025-01-24","current":-1.161757,"twenty":-5.915807,"median":-2.979017,"eighty":-1.494875,"marketCap":95959947},{"date":"2025-01-31","current":-1.161757,"twenty":-5.903095,"median":-2.929407,"eighty":-1.488648,"marketCap":95959947},{"date":"2025-02-07","current":-1.349615,"twenty":-5.866578,"median":-2.898144,"eighty":-1.483292,"marketCap":111476874},{"date":"2025-02-14","current":-1.339728,"twenty":-5.845976,"median":-2.867984,"eighty":-1.475904,"marketCap":110660194},{"date":"2025-02-21","current":-1.428714,"twenty":-5.840903,"median":-2.849084,"eighty":-1.470774,"marketCap":118010317},{"date":"2025-02-28","current":-1.221081,"twenty":-5.802851,"median":-2.826641,"eighty":-1.464477,"marketCap":100860029},{"date":"2025-03-07","current":-1.161757,"twenty":-5.792023,"median":-2.806561,"eighty":-1.459282,"marketCap":95959947},{"date":"2025-03-14","current":-1.022595,"twenty":-5.775967,"median":-2.759312,"eighty":-1.454736,"marketCap":86159782},{"date":"2025-03-21","current":-1.019223,"twenty":-5.771141,"median":-2.735688,"eighty":-1.448292,"marketCap":85875622},{"date":"2025-03-28","current":-1.046919,"twenty":-5.73309,"median":-2.709701,"eighty":-1.443752,"marketCap":88209199},{"date":"2025-04-04","current":-0.925055,"twenty":-5.730666,"median":-2.690647,"eighty":-1.436552,"marketCap":77941461},{"date":"2025-04-11","current":-0.847506,"twenty":-5.708015,"median":-2.664255,"eighty":-1.428714,"marketCap":71407447},{"date":"2025-04-17","current":-0.836427,"twenty":-5.707781,"median":-2.644735,"eighty":-1.423644,"marketCap":70474016}],"updateTime":1745257724268}}}